Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (1) , 43-51
- https://doi.org/10.1016/0006-2952(86)90553-8
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Electrophilic intermediate in the reactions of a 2-(hydroxyamino)imidazole. A model for biological effects of reduced nitroimidazolesJournal of the American Chemical Society, 1985
- Activity of Nitro-Compounds Against Strains of Escherichia Coli Deficient in DNA RepairJournal of Pharmacy and Pharmacology, 1980
- Fate of Cardiology Research Originally Published in Abstract Form | NEJMNew England Journal of Medicine, 1980
- BACTEROIDES FRAGILIS RESISTANT TO METRONIDAZOLE AFTER LONG-TERM THERAPYThe Lancet, 1978
- The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Primary Target of 1-Methyl-2-nitro-5-vinylimidazole is DNAJournal of General Microbiology, 1977
- Radiosensitizers of hypoxic cells in solid tumoursCancer Treatment Reviews, 1976
- Mammalian cell toxicity of nitro compounds: Dependence upon reduction potentiaklBiochemical and Biophysical Research Communications, 1976
- Oxygen inhibition of nitroreductase: Electron transfer from nitro radical-anions to oxygenBiochemical and Biophysical Research Communications, 1976
- Metronidazole (Flagyl): Degradation by the Intestinal FloraXenobiotica, 1976
- Mutagenicity of metronidazole: Activation by mammalian liver microsomesBiochemical and Biophysical Research Communications, 1975